Popular Articles

Thiarabine Demonstrates A Reduction Of Both Inflammatory And Erosive Disease Parameters In Rheumatoid Arthritis
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA). In a well-established animal model for RA, an exceptional restoration of joint structure was observed in the studies, which were conducted at Wayne State University School of Medicine and at Southern Research Institute.

Prevention Efforts Have Little Success In Reducing Illness, Cost
As health reform heats up, many lawmakers agree that the government should take a larger role in preventing disease. However, the Wall Street Journal reports that "many previous government prevention efforts aimed at costly chronic diseases have had little success in reducing illness or costs."
News of the day
GlaxoSmithKline And Genmab Announce Top-line Results For Ofatumumab In Rheumatoid Arthritis
GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced preliminary top-line results from a Phase III study of ofatumumab administered intravenously for the treatment of rheumatoid arthritis (RA) in patients who had an inadequate response to methotrexate. The study met the primary endpoint, ACR20 at 24 weeks, which indicates a 20 percent or greater improvement in the number of swollen and tender joints, as well as improvements in other disease-activity measures.
Oncology

Statistical Press Notice - Direct Access Audiology Referral To Treatment (RTT) Times Data March 2009, UK

- The "Improving Access to Audiology Services in England", document in March 2007 by stated that: "Improving Access to Audiology Services in England sets out a simple aspiration: for local health systems to transform the experience of the audiology service for all their patients. This requires a radical reduction in waiting...no local health system will be credible in claiming success on 18 weeks if it does not make excellent progress in tackling long waiting times affecting large numbers of its local population, " - Data to monitor against this aspiration is today being published for the sixth time. Main Points - Data is being published on Direct Access Audiology patients whose pathways were completed during March 2009 (completed pathways) and on those patients who were still waiting at the end of March 2009 (incomplete pathways) - Publication is an important mechanism in order to improve coverage and completeness of the data. - A data completeness assessment is being published alongside the figures on completed pathways. Details on the data completeness methodology are available on the departmental website. - Currently national data completeness is 103%. However, there are a range of values across the providing organisations. The department continues to work with providing organisations. - The data completeness assessment compares the number of completed pathways (with a known clock start) reported in the Direct Access Audiology RTT return against the expected number of pathways. - Where possible, we have used a 5 month moving average of DM01 Audiological Assessment Waiting List Activity to assess the denominator for completeness. * Where there has either been missing data or an evident discontinuity then this has been addressed in calculating their completeness score - In total, 35,887 patients, for whom English commissioners are responsible, completed their Direct Access Audiology RTT pathway during March 2009. - The NHS reported both the clock stop and the clock start 35,869 (99.9%) of completed Direct Access Audiology RTT pathways. - Of those pathways with both a known clock stop and a known clock start, 99.4% of patients completed their referral to treatment pathway within 18 weeks. - Revised data for previous months" published data is available on the DH website Additional Information Full details of Direct Access Audiology RTT data for individual organisations is available here. Department of Health, UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):